Journal metric profile

Stem Cells Translational Medicine

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 4.900 2025 metric year
5-Year Impact Factor 5.500 Longer citation window
JCR Quartile Q2 Subject-category quartile
JCR Category Rank Sep-32 Recorded category rank

Stem Cells Translational Medicine JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Stem Cells Translational Medicine metric snapshot

Stem Cells Translational Medicine has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is OXFORD UNIV PRESS. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 4.900. The five-year Journal Impact Factor is 5.500, giving a second citation window for comparison. The journal is recorded in quartile Q2 for its listed JCR category.

Category position and quartile

The JCR category rank stored in this record is “Sep-32”. Readers should verify non-standard imported rank formats against the official JCR record. Its listed quartile is Q2. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (5.500) is 0.600 points higher than the standard Journal Impact Factor (4.900). Without journal self-citations, the Impact Factor is 4.700, a difference of 0.200 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 1.210. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Stem Cells Translational Medicine lists total cites: 7,400; total articles: 63; citable items: 85. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 6.7 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 6.8 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Stem Cells Translational Medicine is identified in this directory by print ISSN 2157-6564 and electronic ISSN 2157-6580. The publisher is recorded as OXFORD UNIV PRESS. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameStem Cells Translational Medicine
Abbreviated journalSTEM CELL TRANSL MED
PublisherOXFORD UNIV PRESS
Metric year2025
Overall rank2,094
ISSN2157-6564
eISSN2157-6580
Total cites7,400
Total articles63
Citable items85
Cited half-life6.7 years
Citing half-life6.8 years
JCR-based Journal Impact Factor4.900
5-Year Impact Factor5.500
Impact Factor without journal self-cites4.700
Journal Citation Indicator1.210
JCR Impact Factor quartileQ2
JCR category rankSep-32
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Stem Cells Translational Medicine?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Stem Cells Translational Medicine is 4.900 for the 2025 metric year.

What are the JCR quartile and category rank of Stem Cells Translational Medicine?

Stem Cells Translational Medicine is listed with quartile Q2 and category rank Sep-32. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Stem Cells Translational Medicine?

The five-year Journal Impact Factor recorded for Stem Cells Translational Medicine is 5.500. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Stem Cells Translational Medicine?

Stem Cells Translational Medicine is listed in this directory as being published by OXFORD UNIV PRESS.

Additional records from the same publisher or with a similar listed JCR Impact Factor.